International Clinical Trial: Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313241) titled 'Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Texas Southwestern Medical Center

Condition: Prostate Cancer

Intervention: Radiation: Prostate Fossa Radiotherapy Radiation: Pelvic nodal Radiotherapy

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: November 14, 2025

Target Sample Size: ...